The feasibility and efficacy of robot-assisted central pancretectomy

The feasibility and efficacy of robot-assisted central pancretectomy using da Vinci surgical system: The pase I clinical trial

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT1032240410

Enrollment

Registered

2024-10-16

Start date

2024-10-16

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Low malignant tumor located at pancreas body or tail

Interventions

To perform robot-assisted central pancreatectomy for pancreas body or tail low malignant tumor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age 20 to 80 2. PS 0 or 1 3. Noramal organ fuction 4. Future remnant pancreas more than 3cm 5. Written informed consent

Exclusion criteria

Exclusion criteria: 1. Contraindications for laparoscopic surgery 2. Pancreas ductal adenocarcinoma 3. Decision of principal investigator

Design outcomes

Primary

Measure	Time frame
morbidity according to Clavien-Dingo grade system	—

Secondary

Measure	Time frame
adverse event, operation time, bleeding, length of hospital stay, R0 resection rate	—

Contacts

Public ContactYoshinori Takeda

Juntendo University Hospital

yo-takeda@juntendo.ac.jp+81-3-3813-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026